说到微创医疗 (00853)，最近股票一路下行，这让许多人关注到微创的状况：它到底行不行？
对于公司的运营，我不敢妄加评论。但是，对于管理层的表现，我只能感到失望。
身为多年关注微创的投资者，我曾因微创的成就而欣喜万分。可现在，却为微创的表现感到羞耻，为管理层的轻率行为感到愤怒。
当管理层自诩 “不以短期利润为目标，把握创新、出海两大行业发展机遇” 时，我们只能感到惋惜。
但是，我对此有了新的想法。
看看$Endovastec(688016.SH)和$WuXi AppTec(603259.SH)的发展，也许能给我们带来思路。
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments